HEADER CHAPERONE/SURFACE ACTIVE PROTEIN 12-OCT-06 2J7L TITLE E.COLI P PILUS CHAPERONE PAPD IN COMPLEX WITH A PILUS TITLE 2 BIOGENESIS INHIBITOR, PILICIDE 2C COMPND MOL_ID: 1; COMPND 2 MOLECULE: CHAPERONE PROTEIN PAPD; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: RESIDUES 22-239; COMPND 5 SYNONYM: PAPD; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ESCHERICHIA COLI; SOURCE 3 ORGANISM_TAXID: 562; SOURCE 4 STRAIN: J96; SOURCE 5 ATCC: 700336; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: C600; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PMMB91 KEYWDS FIMBRIA, INHIBITOR, CHAPERONE, PERIPLASMIC, IMMUNOGLOBULIN KEYWDS 2 DOMAIN, CHAPERONE/SURFACE ACTIVE PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR H.REMAUT,J.S.PINKNER,S.J.HULTGREN,F.ALMQVIST,G.WAKSMAN REVDAT 4 24-FEB-09 2J7L 1 VERSN REVDAT 3 30-NOV-06 2J7L 1 JRNL REVDAT 2 14-NOV-06 2J7L 1 REMARK HETATM REVDAT 1 01-NOV-06 2J7L 0 JRNL AUTH J.S.PINKNER,H.REMAUT,F.BUELENS,E.MILLER,V.ABERG, JRNL AUTH 2 N.PEMBERTON,M.HEDENSTROM,A.LARSSON,P.SEED, JRNL AUTH 3 G.WAKSMAN,S.J.HULTGREN,F.ALMQVIST JRNL TITL RATIONALLY DESIGNED SMALL COMPOUNDS INHIBIT PILUS JRNL TITL 2 BIOGENESIS IN UROPATHOGENIC BACTERIA. JRNL REF PROC.NATL.ACAD.SCI.USA V. 103 17897 2006 JRNL REFN ISSN 0027-8424 JRNL PMID 17098869 JRNL DOI 10.1073/PNAS.0606795103 REMARK 2 REMARK 2 RESOLUTION. 2.6 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES, PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.6 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 15 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.0 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 95.1 REMARK 3 NUMBER OF REFLECTIONS : 9815 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.2324 REMARK 3 FREE R VALUE : 0.2726 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.0 REMARK 3 FREE R VALUE TEST SET COUNT : 512 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1664 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 34 REMARK 3 SOLVENT ATOMS : 52 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 50.9 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 54.02 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -14.926 REMARK 3 B22 (A**2) : -14.926 REMARK 3 B33 (A**2) : 29.852 REMARK 3 B12 (A**2) : -7.157 REMARK 3 B13 (A**2) : 0.000 REMARK 3 B23 (A**2) : 0.000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008812 REMARK 3 BOND ANGLES (DEGREES) : 1.25549 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.440 ; 1.5 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.477 ; 2.0 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.051 ; 2.0 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.244 ; 2.5 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : 0.343506 REMARK 3 BSOL : 45.463 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : DNA-RNA_REP.PARAM REMARK 3 PARAMETER FILE 3 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : ION.PARAM REMARK 3 PARAMETER FILE 5 : P-048.PARAM REMARK 3 PARAMETER FILE 6 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : DNA-RNA.TOP REMARK 3 TOPOLOGY FILE 3 : WATER.TOP REMARK 3 TOPOLOGY FILE 4 : ION.TOP REMARK 3 TOPOLOGY FILE 5 : P-048.TOPOL REMARK 3 TOPOLOGY FILE 6 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2J7L COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 12-OCT-06. REMARK 100 THE PDBE ID CODE IS EBI-30214. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 25-FEB-05 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 6.00 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID14-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9756 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : CCP4 (SCALA) REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 20651 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.600 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 13.700 REMARK 200 R MERGE (I) : 0.09000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 23.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.60 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.74 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 14.10 REMARK 200 R MERGE FOR SHELL (I) : 0.43000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 7.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1QPP REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 61.20 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.19 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 16 % PEG 4000, 100MM TRIS HCL REMARK 280 PH 8.5 AND 200 MM LI2SO4 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 63 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z REMARK 290 3555 -X+Y,-X,Z REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+1/2 REMARK 290 6555 X-Y,X,Z+1/2 REMARK 290 7555 Y,X,-Z REMARK 290 8555 X-Y,-Y,-Z REMARK 290 9555 -X,-X+Y,-Z REMARK 290 10555 -Y,-X,-Z+1/2 REMARK 290 11555 -X+Y,Y,-Z+1/2 REMARK 290 12555 X,X-Y,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 60.99600 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 60.99600 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 60.99600 REMARK 290 SMTRY1 7 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 7 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 9 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 9 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 9 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 10 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 10 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 10 0.000000 0.000000 -1.000000 60.99600 REMARK 290 SMTRY1 11 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 11 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 11 0.000000 0.000000 -1.000000 60.99600 REMARK 290 SMTRY1 12 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 12 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 12 0.000000 0.000000 -1.000000 60.99600 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 GENERATING THE BIOMOLECULE REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 121.99200 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 HOH Z 52 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LYS A 99 REMARK 465 ALA A 100 REMARK 465 ASN A 101 REMARK 465 VAL A 102 REMARK 465 LEU A 103 REMARK 465 LYS A 216 REMARK 465 GLU A 217 REMARK 465 LYS A 218 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O PRO A 94 - O HOH A 2028 2.15 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 65 -144.96 -104.66 REMARK 500 ARG A 96 10.57 -63.76 REMARK 500 ILE A 105 72.91 -104.94 REMARK 500 THR A 109 147.20 -175.45 REMARK 500 ARG A 176 62.25 39.70 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE XC2 A1216 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1N0L RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE PAPD CHAPERONE (C- REMARK 900 TERMINALLY 6XHISTIDINE-TAGGED) BOUND TO THE REMARK 900 PAPE PILUS SUBUNIT (N-TERMINAL-DELETED) FROM REMARK 900 UROPATHOGENIC E. COLI REMARK 900 RELATED ID: 1PDK RELATED DB: PDB REMARK 900 PAPD-PAPK CHAPERONE-PILUS SUBUNIT COMPLEX REMARK 900 FROM E.COLI P PILUS REMARK 900 RELATED ID: 1QPP RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURES OF SELF CAPPING PAPD REMARK 900 CHAPERONE HOMODIMERS REMARK 900 RELATED ID: 1QPX RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURES OF SELF-CAPPING PAPD REMARK 900 CHAPERONE HOMODIMERS REMARK 900 RELATED ID: 2J2Z RELATED DB: PDB REMARK 900 X-RAY STRUCTURE OF THE CHAPERONE PAPD IN REMARK 900 COMPLEX WITH THE PILUS TERMINATOR SUBUNIT REMARK 900 PAPH AT 2.3 ANGSTROM RESOLUTION REMARK 900 RELATED ID: 3DPA RELATED DB: PDB REMARK 900 PAPD DBREF 2J7L A 1 218 UNP P15319 PAPD_ECOLI 22 239 SEQADV 2J7L ASP A 81 UNP P15319 GLU 81 CONFLICT SEQRES 1 A 218 ALA VAL SER LEU ASP ARG THR ARG ALA VAL PHE ASP GLY SEQRES 2 A 218 SER GLU LYS SER MET THR LEU ASP ILE SER ASN ASP ASN SEQRES 3 A 218 LYS GLN LEU PRO TYR LEU ALA GLN ALA TRP ILE GLU ASN SEQRES 4 A 218 GLU ASN GLN GLU LYS ILE ILE THR GLY PRO VAL ILE ALA SEQRES 5 A 218 THR PRO PRO VAL GLN ARG LEU ASP PRO GLY ALA LYS SER SEQRES 6 A 218 MET VAL ARG LEU SER THR THR PRO ASP ILE SER LYS LEU SEQRES 7 A 218 PRO GLN ASP ARG GLU SER LEU PHE TYR PHE ASN LEU ARG SEQRES 8 A 218 GLU ILE PRO PRO ARG SER GLU LYS ALA ASN VAL LEU GLN SEQRES 9 A 218 ILE ALA LEU GLN THR LYS ILE LYS LEU PHE TYR ARG PRO SEQRES 10 A 218 ALA ALA ILE LYS THR ARG PRO ASN GLU VAL TRP GLN ASP SEQRES 11 A 218 GLN LEU ILE LEU ASN LYS VAL SER GLY GLY TYR ARG ILE SEQRES 12 A 218 GLU ASN PRO THR PRO TYR TYR VAL THR VAL ILE GLY LEU SEQRES 13 A 218 GLY GLY SER GLU LYS GLN ALA GLU GLU GLY GLU PHE GLU SEQRES 14 A 218 THR VAL MET LEU SER PRO ARG SER GLU GLN THR VAL LYS SEQRES 15 A 218 SER ALA ASN TYR ASN THR PRO TYR LEU SER TYR ILE ASN SEQRES 16 A 218 ASP TYR GLY GLY ARG PRO VAL LEU SER PHE ILE CYS ASN SEQRES 17 A 218 GLY SER ARG CYS SER VAL LYS LYS GLU LYS HET XC2 A1216 34 HETNAM XC2 (3R)-8-CYCLOPROPYL-6-(MORPHOLIN-4-YLMETHYL)- HETNAM 2 XC2 7-(1-NAPHTHYLMETHYL)-5-OXO-2,3-DIHYDRO-5H-[1, HETNAM 3 XC2 3]THIAZOLO[3,2-A]PYRIDINE-3-CARBOXYLIC ACID FORMUL 2 XC2 C27 H28 N2 O4 S FORMUL 3 HOH *52(H2 O1) HELIX 1 1 PRO A 73 LEU A 78 5 6 HELIX 2 2 PRO A 117 LYS A 121 5 5 HELIX 3 3 TRP A 128 LEU A 132 5 5 HELIX 4 4 SER A 159 GLY A 166 1 8 SHEET 1 AA 4 VAL A 2 LEU A 4 0 SHEET 2 AA 4 SER A 17 ASN A 24 -1 O SER A 23 N SER A 3 SHEET 3 AA 4 LYS A 64 THR A 71 -1 O SER A 65 N ILE A 22 SHEET 4 AA 4 VAL A 50 THR A 53 -1 O ILE A 51 N SER A 70 SHEET 1 AB 5 ARG A 8 ASP A 12 0 SHEET 2 AB 5 THR A 109 ARG A 116 1 O LYS A 112 N ALA A 9 SHEET 3 AB 5 SER A 84 ILE A 93 -1 O SER A 84 N TYR A 115 SHEET 4 AB 5 TYR A 31 GLU A 38 -1 O LEU A 32 N ILE A 93 SHEET 5 AB 5 VAL A 56 LEU A 59 -1 O GLN A 57 N ALA A 33 SHEET 1 AC 8 VAL A 171 LEU A 173 0 SHEET 2 AC 8 VAL A 151 GLY A 157 -1 O VAL A 151 N LEU A 173 SHEET 3 AC 8 TYR A 190 TYR A 193 -1 O TYR A 190 N GLY A 157 SHEET 4 AC 8 VAL A 202 ASN A 208 -1 O LEU A 203 N LEU A 191 SHEET 5 AC 8 ARG A 211 VAL A 214 -1 O ARG A 211 N ASN A 208 SHEET 6 AC 8 LEU A 134 VAL A 137 -1 O LEU A 134 N CYS A 212 SHEET 7 AC 8 GLY A 140 ASN A 145 -1 O GLY A 140 N VAL A 137 SHEET 8 AC 8 SER A 177 LYS A 182 -1 O SER A 177 N ASN A 145 SSBOND 1 CYS A 207 CYS A 212 1555 1555 2.04 CISPEP 1 GLY A 48 PRO A 49 0 0.38 CISPEP 2 THR A 53 PRO A 54 0 -0.09 SITE 1 AC1 10 LEU A 32 ILE A 46 THR A 47 ALA A 52 SITE 2 AC1 10 THR A 53 PRO A 55 ARG A 58 PRO A 94 SITE 3 AC1 10 PRO A 95 ARG A 96 CRYST1 94.315 94.315 121.992 90.00 90.00 120.00 P 63 2 2 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010603 0.006122 0.000000 0.00000 SCALE2 0.000000 0.012243 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008197 0.00000 MASTER 342 0 1 4 17 0 3 6 0 0 0 17 END